Kalypsys, Inc

Kalypsys, a private, San Diego-based company, utilizes proprietary automated technologies to profile small molecule drug leads early in the discovery process and thereby enhance and accelerate subsequent drug development through clinical proof-of-concept. The company has compiled a large chemical “drug lead” library and leverages an integrated drug discovery, medicinal chemistry, and experimental medicine team. Our mission is to discover, develop and commercialize our products alone and in strategic partnerships

Contact Details: 10420 Wateridge Circle San Diego California 92121 United States of America Tel: 858.754.3300 Fax: 858.754.3301 Email: info@kalypsys.com WWW: www.kalypsys.com/

Loading...

Press Releases on Kalypsys, Inc:
Fate Therapeutics Adds Pratik Multani, M.D., M.S., as Vice President Clinical Development to Advance Upcoming Clinical Programs of Stem Cell Modulators	18th May, 2009	Fate Therapeutics, Inc.	LA JOLLA, Calif., May 18 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that it has further expanded the Company's executive team with the addition of Pratik Multani, M.D., M.S., as

BioNews Results for Kalypsys, Inc:
PRIMECAP Management Top Holdings: Amgen Inc., Eli Lilly and Company, Novartis AG, FedEx Corp., Google Inc., Me	Guru Focus:  Nov 22 2009 3:56PM Matching: inc
Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Cogent Inc, AMERICAN PUBLIC EDUCATION, INC, Whitne	Guru Focus:  Nov 22 2009 5:13PM Matching: inc
N.J. index reaches a yearly high	Asbury Park Press:  Nov 22 2009 12:49PM Matching: inc
Analyst Choice Brings New Analysis on Level 3 Communications Inc., Arris Group Inc., Virgin Media Inc., The South Financial Group Inc., Wynn Resorts Limited and AMAG Pharmaceuticals Inc.	Individual.com:  Nov 21 2009 6:41AM Matching: inc
Stocks That Stand Out For Nov. 20th, 2009 Are ARTS, RFMD, CLDS, ACTC	Pharmacy Choice:  Nov 21 2009 1:27PM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Kalypsys, Inc news.

Kalypsys, Inc Patents:
US Patent No.	Title
7517884	Sulfonyl-substituted bicyclic compounds as modulators of PPAR
7494999	Sulfonyl-substituted bicyclic compounds as modulators of PPAR
7470722	Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
7381749	Sulfonamides as inhibitors of histone deacetylase for the treatment of disease
7271195	Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
→View more Kalypsys, Inc patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 652 times since April 2007, the link to the organisation's website has been followed 92 times

Recent Search Terms used to find this page: Kalypsys Inc | kalypsys | kalypsys | Kalypsys 2009 | Kalypsys | Kalypsys | kalypsys 2009 | Kalypsys san diego 2009 | kalypsys 2009 | kalypsys 2009 | .

Search for more companies in San Diego

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Kalypsys, Inc